Core offer
A prescription medicine for adults with moderate to severe plaque psoriasis and active psoriatic arthritis.
Tremfya: A prescription medicine for adults with moderate to severe plaque psoriasis… · Apr 29–Jun 11, 2026
ChurnedThis campaign promotes Tremfya as a prescription medicine for adults with moderate to severe plaque psoriasis and active psoriatic arthritis, addressing symptoms like joint pain and swelling by offering a path to relief.
Apr 29, 2026
First seen
Jun 11, 2026
Last seen
6
Reads
4
Shows
3
Active months
1:03
Avg. length
13-week activity
Public campaign reads by observed week
1
1
2
1
Renewal signals
30 dayYes
60 dayNo
90 dayNo
Promo-code persistence
No recurring promo code was observed.
Shows
Where the campaign appeared
Representative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
The Rest Is History·665. Britain in the 70s: The Bailout from Hell (Part 4)
Est. value ~$2.9Krange $540–$20K
Did you know about one in three people with plaque psoriasis may also develop psoriatic arthritis, which causes joint pain, stiffness, and swelling? Does this sound like you? Listen to what it sounds like to be a million miles away. Tremfya guselkumab taken by injection is a prescription medicine for adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills or phototherapy and for adults with active psoriatic arthritis. Serious allergic reactions and increased risk of infections and liver problems may occur. Before treatment, your doctor should check you for infections and tuberculosis. Tell your doctor if you have an infection, flu like symptoms, or if you need a vaccine. Imagine being a million miles away. Explore what's possible. Ask your doctor about Trimvia. Tap this ad to learn more about Trimvia, including important safety information.
More campaigns from Tremfya
Other published campaigns from this sponsor
Tremfya: Prescription medicine for adults with moderately to severely active Crohn's… · Feb 22–Jul 12, 2026Churned
This campaign promotes Tremfya as a prescription medicine for adults with moderately to severely active Crohn's disease or ulcerative colitis, emphasizing the choice between self-injection or intravenous infusion from the start.
29 reads11 showsLast seen Jul 12
Tremfya Campaign 1Churned
Tremfya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and ulcerative colitis, providing options for self-injection or intravenous infusion.
4 reads3 showsLast seen Jun 9
Tremfya: Self injection or intravenous infusion from the start · May 14–19, 2026Churned
Tremfya advertising observed across this podcast campaign.
2 reads2 showsLast seen May 19
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.